Differences about effectiveness of CGM and treatment satisfaction between dulaglutide and omarigliptin.
Phase of Trial: Phase II
Latest Information Update: 21 Oct 2017
At a glance
- Drugs Dulaglutide (Primary) ; Omarigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Oct 2017 Planned End Date changed from 31 May 2017 to 31 May 2018.
- 20 Jul 2017 New trial record
- 13 Jun 2017 Interim results (n=7) comparing glucose lowering effects of Dulaglutide and Omarigliptin, presented at the 77th Annual Scientific Sessions of the American Diabetes Association.